Identification of the H3K36me3 reader LEDGF/p75 in the pancancer landscape and functional exploration in clear cell renal cell carcinoma

Identification of the H3K36me3 reader LEDGF/p75 in the pancancer landscape and functional exploration in clear cell renal cell carcinoma

Lens epithelium-derived growth factor (LEDGF/p75) is a reader of epigenetic marks and a potential target for therapeutic intervention. Its involvement in human immunodeficiency virus (HIV) integration and the development of leukemia driven by MLL (also known as KMT2A) gene fusion make it an attracti...

Full description

Bibliographic Details
Main Authors:	Yuwei Zhang, Wei Guo, Yangkun Feng, Longfei Yang, Hao Lin, Pengcheng Zhou, Kejie Zhao, Lin Jiang, Bing Yao, Ninghan Feng
Format:	Article
Language:	English
Published:	Elsevier 2023-01-01
Series:	Computational and Structural Biotechnology Journal
Subjects:	LEDGF/p75 H3K36me3 Pancancer SETD2 Clear cell renal cell carcinoma
Online Access:	http://www.sciencedirect.com/science/article/pii/S2001037023002982

Similar Items

The selenium-containing drug ebselen potently disrupts LEDGF/p75-HIV-1 integrase interaction by targeting LEDGF/p75
by: Da-Wei Zhang, et al.
Published: (2020-01-01)

CCNF is a potential pancancer biomarker and immunotherapy target
by: Lifang Wei, et al.
Published: (2023-04-01)

Comprehensive Analysis Reveals the Potential Roles of CDKN3 in Pancancer and Verification in Endometrial Cancer
by: Gao C, et al.
Published: (2023-12-01)

The LEDGF/p75 Integrase Binding Domain Interactome Contributes to the Survival, Clonogenicity, and Tumorsphere Formation of Docetaxel-Resistant Prostate Cancer Cells
by: Greisha L. Ortiz-Hernandez, et al.
Published: (2021-10-01)

Glucocorticoid Receptor Regulates and Interacts with LEDGF/p75 to Promote Docetaxel Resistance in Prostate Cancer Cells
by: Evelyn S. Sanchez-Hernandez, et al.
Published: (2023-08-01)

Transgenic expression of the human LEDGF/p75 gene relieves the species barrier against HIV-1 infection in mouse cells
by: Takuya eTada, et al.
Published: (2013-12-01)

LEDGF/p75 Is Required for an Efficient DNA Damage Response
by: Victoria Liedtke, et al.
Published: (2021-05-01)

Does the LHPP gene share a common biological function in pancancer progression?
by: Kai Guo, et al.
Published: (2022-11-01)

HRP-2 determines HIV-1 integration site selection in LEDGF/p75 depleted cells
by: Schrijvers Rik, et al.
Published: (2012-10-01)

LEDGIN-mediated Inhibition of Integrase–LEDGF/p75 Interaction Reduces Reactivation of Residual Latent HIV
by: Lenard S. Vranckx, et al.
Published: (2016-06-01)

Evaluation of a flavonoid library for inhibition of interaction of HIV-1 integrase with human LEDGF/p75 towards a structure–activity relationship
by: Zhi-Hui Yin, et al.
Published: (2022-12-01)

Dihydroxyphenyl- and Heteroaromatic-Based Thienopyrimidinones to Tackle HIV-1 LEDGF/p75-Dependent IN Activity
by: Graziella Tocco, et al.
Published: (2023-09-01)

LEDGF/p75 Deficiency Increases Deletions at the HIV-1 cDNA Ends
by: Murilo T. D. Bueno, et al.
Published: (2017-09-01)

Characterization of H3.3K36M as a tool to study H3K36 methylation in cancer cells
by: Saumya M. Sankaran, et al.
Published: (2017-11-01)

Integrative and Comprehensive Pancancer Analysis of Regulator of Chromatin Condensation 1 (RCC1)
by: Changwu Wu, et al.
Published: (2021-07-01)

Chromobox Homolog 8 (CBX8) in Human Tumor Carcinogenesis and Prognosis: A Pancancer Analysis Using Multiple Databases
by: Dongjie Shi, et al.
Published: (2021-09-01)

A pancancer analysis of the carcinogenic role of receptor-interacting serine/threonine protein kinase-2 (RIPK2) in human tumours
by: Hanqun Zhang, et al.
Published: (2022-04-01)

Over-Expression of LEDGF/p75 in HEp-2 Cells Enhances Autoimmune IgG Response in Patients with Benign Prostatic Hyperplasia—A Novel Diagnostic Approach with Therapeutic Consequence?
by: Victoria Liedtke, et al.
Published: (2023-03-01)

Allosteric Integrase Inhibitor Influences on HIV-1 Integration and Roles of LEDGF/p75 and HDGFL2 Host Factors
by: Parmit Kumar Singh, et al.
Published: (2022-08-01)

SETD2-H3K36ME3: an important bridge between the environment and tumors
by: Jiahui He, et al.
Published: (2023-06-01)

Histone methyltransferase SETD2: An epigenetic driver in clear cell renal cell carcinoma
by: Mengxue Yu, et al.
Published: (2023-03-01)

Pancancer landscape analysis of the thymosin family identified TMSB10 as a potential prognostic biomarker and immunotherapy target in glioma
by: Ye Xiong, et al.
Published: (2022-09-01)

A Pancancer Analysis of the Expression Landscape and Clinical Relevance of Fibroblast Growth Factor Receptor 2 in Human Cancers
by: Juanni Li, et al.
Published: (2021-04-01)

ACYP1 Is a Pancancer Prognostic Indicator and Affects the Immune Microenvironment in LIHC
by: Lingyi Zhou, et al.
Published: (2022-05-01)

Downregulation of trimethyl transferase SETD2 promotes migration and proliferation of colorectal cancer cell
by: CUI Ang, DING Jiazeng, CHEN Haizhen, SHEN Xiaohui, LI Chaofei, LIU Guoliang
Published: (2020-03-01)

Spectrum of Mesenchymal–Epithelial Transition Aberrations and Potential Clinical Implications: Insights From Integrative Pancancer Analysis
by: Juanni Li, et al.
Published: (2020-10-01)

Integrated pancancer analysis reveals the oncogene characteristics and prognostic value of DIP2B in breast cancer
by: Chengyang Song, et al.
Published: (2023-03-01)

Structural and functional specificity of H3K36 methylation
by: Ulysses Tsz Fung Lam, et al.
Published: (2022-05-01)

Histone Methyltransferase SETD2 Is Required for Porcine Early Embryonic Development
by: Weini Shao, et al.
Published: (2022-08-01)

Pancancer Analysis of the Oncogenic and Prognostic Role of <i>NOL7</i>: A Potential Target for Carcinogenesis and Survival
by: Qiaojun Liu, et al.
Published: (2022-08-01)

Interferon-Induced Transmembrane Protein 3 Shapes an Inflamed Tumor Microenvironment and Identifies Immuno-Hot Tumors
by: Yun Cai, et al.
Published: (2021-08-01)

SETD2 mutations in primary central nervous system tumors
by: Angela N. Viaene, et al.
Published: (2018-11-01)

MXD3 as an Immunological and Prognostic Factor From Pancancer Analysis
by: Xiaoyu Zhang, et al.
Published: (2021-11-01)

OAS3 is a Co-Immune Biomarker Associated With Tumour Microenvironment, Disease Staging, Prognosis, and Treatment Response in Multiple Cancer Types
by: Xin-yu Li, et al.
Published: (2022-05-01)

Corrigendum: MXD3 as an Immunological and Prognostic Factor From Pancancer Analysis
by: Xiaoyu Zhang, et al.
Published: (2021-12-01)

Histone Lysine Methyltransferase SETD2 Regulates Coronary Vascular Development in Embryonic Mouse Hearts
by: Fengling Chen, et al.
Published: (2021-04-01)

SETD2 loss in renal epithelial cells drives epithelial‐to‐mesenchymal transition in a TGF‐β‐independent manner
by: Tianchu Wang, et al.
Published: (2024-01-01)

Genetic polymorphisms of histone methyltransferase SETD2 predicts prognosis and chemotherapy response in Chinese acute myeloid leukemia patients
by: Suwei Wang, et al.
Published: (2019-03-01)

SETD1A‐mediated H3K4me3 methylation upregulates lncRNA HOXC‐AS3 and the binding of HOXC‐AS3 to EP300 and increases EP300 stability to suppress the ferroptosis of NSCLC cells
by: Zhenliang Shi, et al.
Published: (2023-09-01)

The H3K4 methyltransferase Setd1b is essential for hematopoietic stem and progenitor cell homeostasis in mice
by: Kerstin Schmidt, et al.
Published: (2018-06-01)